Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) as an add-on ...

Public health, access to healthcare services, and food and nutrition are some of the most important issues facing people ...

One of the candidates included in the deal has already shown promise in a phase 1a advanced breast cancer study ...

Bristol Myers Squibb (BMS) has announced positive results from a phase 3b/4 study of its oral TYK2 inhibitor Sotyktu ...

Women have played a crucial role in rare disease awareness and better care, overcoming gender biases and systemic challenges ...

The British Skin Foundation’s (BSF) skin research programme has received a £10,000 donation from Circle Health Group (CHG) ...

Many initiatives have tried to address this partnership challenge: the Healthcare Communications Association’s (HCA) own ...

Johnson & Johnson (J&J) and Legend Biotech have shared positive long-term results for their BCMA-directed T-cell ...

Yuvanci (single tablet combination therapy [STCT] of macitentan and tadalafi) has been approved by the European Commission ...

Yesterday marked World Heart Day, and Medscape is at the forefront with a featured article in Media Planet's cardiology ...

Ipsen’s Kayfanda (odevixibat) has been approved by the European Commission (EC) under exceptional circumstances to treat ...

Medscape wants to take the opportunity to look back and recap what was accomplished at ESC 2024. At this year’s event, ...